The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 19 , ISSUE 12 ( December, 2018 ) > List of Articles


Evaluation of Effect of Glucosamine-Chondroitin Sulfate, Tramadol, and Sodium Hyaluronic Acid on Expression of Cytokine Levels in Internal Derangement of Temporomandibular Joint

Junaid MH Kapadia, Srinivas Ganti, Prashant Shriram, Arsalan SA Ansari, Anurag Azad, Abhinav Dubey

Keywords : Chondroitin sulfate, Glucosamine, TMJ, Tramadol

Citation Information : Kapadia JM, Ganti S, Shriram P, Ansari AS, Azad A, Dubey A. Evaluation of Effect of Glucosamine-Chondroitin Sulfate, Tramadol, and Sodium Hyaluronic Acid on Expression of Cytokine Levels in Internal Derangement of Temporomandibular Joint. J Contemp Dent Pract 2018; 19 (12):1502-1506.

DOI: 10.5005/jp-journals-10024-2456

License: CC BY-NC 4.0

Published Online: 01-02-2019

Copyright Statement:  Copyright © 2018; The Author(s).


Aim: Evaluation of the effect of glucosamine-chondroitin combination, tramadol, and sodium hyaluronic acid in temporomandibular joint (TMJ) disorders and its impact on the expression of various cytokines such as IL-6, IL-1s, TNF-ƒ¿, and PGE2. Materials and methods: The present study was conducted on 60 patients (males.30, females.30) suffering from internal derangement such as disc displacement with reduction of TMJ. The patients were divided into three groups of 20 each. Group I received a combination of 1.5g of glucosamine and 1.2 g of chondroitin sulfate per day and group II received 50 mg tramadol HCL peroral. Group III received sodium hyaluronate 10 mg/mL, 2 mL injection syringe on each joint. Pain (VAS) scale and maximum mouth opening (MMO) was measured. The level of IL-6, IL-1s, TNF-ƒ¿, and PGE2 levels were measured using Enzyme-linked immuno sorbent assay (ELISA). Results: There was an improvement in maximum mouth opening in all three groups (p < 0.05). There was a reduction in pain in all groups. IL- 1 s, TNF-ƒ¿, and PGE2 leve ls showed reduction while IL-6 showed an increase in value in group II and III. Conclusion: The efficacy of glucosamine chondroitin sulfate, tramadol and hyaluronic acid in TMJ disorders has been found to be effective. Clinical significance: IL-6, IL-1s, TNF-ƒ¿, and PGE2 levels indicate the risk of TMJ disorders. Thus earlier assessment of their levels helps in diagnosis, and better management may be done.

PDF Share
  1. Kostrzewa-Janicka J, Mierzwinska-Nastalska E, Jurkowski P, Okonski P, Nedzi-Gora M. Assessment of temporomandibular joint disease. Adv Exp Med Biol. 2013; 788:207-211.
  2. Kacena MA, Merrel GA, Konda SR, Wilson KM, Xi Y, Horowitz MC. Inflammation and bony changes at the temporomandibular joint. Cells Tissues Organs. 2001; 169:257-264.
  3. Matsumoto K, Honda K, Ohshima M, Yamaguchi Y, Nakajima I, Micke P, et al. Cytokine profile in synovial fluid from patients with internal derangement of the temporomandibular joint: A preliminary study. Dentomaxillofac Radiol. 2006;35:432-441.
  4. Wake M, Hamada Y, Kumagai K, Tanaka N, Ikeda Y, Nakatani Y, et al. Up-regulation of interleukin-6 and vascular endothelial growth factor-A in the synovial fluid of temporomandibular joints affected by synovial chondromatosis. Br J Oral Maxillofac Surg. 2013;51:164-169.
  5. Takano H, Ariyoshi W, Kanno T, Fukuhara E, Ichimiya H, Matayoshi T, et al. Induction of osteoclast-like cells derived from the synovial lavage fluids of patients with temporomandibular joint disorders. Osteoarthritis Cartilage. 2007;15:291-299.
  6. Bruyere O, Reginster JY. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs Aging 2007;24:573-580.
  7. Chan PS, Caron JP, Rosa GJ, Orth MW. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E (2) in articular cartilage explants. Osteoarthritis Cartilage. 2005;13:387-394.
  8. Bouloux GF. Temporomandibular joint pain and synovial fluid analysis: a review of the literature. J Oral Maxillofac Surg 2009;67:2497-504.
  9. Chou MM, Vergnolle N, McDougall JJ, Wallace JL, Marty S, Teskey V et al. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med (Maywood). 2005; 230(4):255-262.
  10. Kaneyama K, Segami N, Nishimura M, Suzuki T, Sato J. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br J Oral Maxillofac Surg. 2002;40:418-423.
  11. Kean WF, Bouchard S, Roderich Gossen E. Women with pain due to osteoarthritis: the efficacy and safety of a oncedaily formulation of tramadol. Pain Med. 2009;10:1001-1011.
  12. Nguyen P, Mohamed SE, Gardiner D, Salinas T. A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: A pilot study. Cranio. 2001;19:130-139.
  13. Mazieres B, Hucher M, Zaim M, Garnero P. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2007;66:639-645.
  14. Shankland WE, 2nd. The effects of glucosamine and chondroitin sulfate on osteoarthritis of the TMJ: a preliminary report of 50 patients. Cranio. 1998;16:230-235.
  15. Quinn JH, Bazan NG. Identification of prostaglandin E2 and leukotrienes B4 in the synovial fluid of painful, dysfunctional temporomandibular joints. J Oral Maxillofac Surg. 1990;48:968-971.
  16. Burch F, Fishman R, Messina N, Corser B, Radulescu F, Sarbu A, et al. A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis. J Pain Symptom Manage. 2007; 34:328-338.
  17. Gencer ZK, Özkiriş M, Okur A, Korkmaz M, Saydam L. A comparative study on the impact of intra-articular injections of hyaluronic acid, tenoxicam and betametasone on the relief of temporomandibular joint disorder complaints. Journal of Cranio-Maxillofacial Surgery. 2014;42(7):1117-1121.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.